Corcoran Nicholas 4

What Happened Nicholas Corcoran, SVP of Supply Chain and Operations at TransMedics Group (TMDX), received equity compensation on July 10, 2026: 11,727 restricted stock units (RSUs) and a 17,784-share stock option award. Both grants were reported with an acquisition price of $0.00 (typical for awards), totaling 29,511 shares subject to future vesting and settlement.

Key Details

• Transaction date: July 10, 2026; Form 4 filed July 14, 2026 (filed on time).
• Grants: 11,727 RSUs (each RSU = contingent right to one share) and a 17,784-share option award (reported as a derivative).
• Vesting for the option: vests at 2.0833% of the option monthly beginning April 10, 2026 and fully vests April 10, 2030, subject to continued service (per footnote).
• Reported acquisition price: $0.00 for both awards (compensation grants, not market purchases).
• Shares owned after transaction: not specified in the provided filing.

Context These are compensation awards, not open-market purchases or sales. RSUs convert to common stock upon vesting; the option vests over ~4 years monthly, subject to continued employment. Such grants are routine executive compensation disclosures and do not by themselves indicate an immediate buy or sell decision.